Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update

Cites (261)

Items 201–260 of 260

1. Finding Multiactivity Substructures by Mining Databases of Drug-Like Compounds
   Robert P. Sheridan · 2003 · Journal of Chemical Information and Computer Sciences
2. Maximizing discovery efficiency with a computationally driven fragment approach.
   William Richard Moore · 2005 · PubMed
3. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors
   Hwangseo Park, Young Jae Bahn, Seong Eon Ryu · 2009 · Bioorganic & Medicinal Chemistry Letters
4. Generation and Selection of Novel Estrogen Receptor Ligands Using the De Novo Structure-Based Design Tool, SkelGen
   Stuart Firth‐Clark, Henriëtte M. G. Willems, Anthony Williams, William R. Harris · 2005 · Journal of Chemical Information and Modeling
5. On Sampling of Fragment Space
   Gergely M. Makara · 2007 · Journal of Medicinal Chemistry
6. Structure‐Based Design, Synthesis, and Antifungal Activity of New Triazole Derivatives
   Chunquan Sheng, Xiaoying Che, Wenya Wang, Shengzheng Wang, Yongbing Cao, Jianzhong Yao, Zhenyuan Miao, Wannian Zhang · 2011 · Chemical Biology & Drug Design
7. A Novel In Silico Approach to Drug Discovery via Computational Intelligence
   David Hecht, Gary B. Fogel · 2009 · Journal of Chemical Information and Modeling
8. Fragment and knowledge-based design of selective GSK-3β inhibitors using virtual screening models
   S. Vadivelan, Barij Nayan Sinha, Sunita Tajne, Sarma A.R.P. Jagarlapudi · 2008 · European Journal of Medicinal Chemistry
9. Small-World Phenomena in Chemical Library Networks: Application to Fragment-Based Drug Discovery
   Naoki Tanaka, Kazuki Ohno, Tatsuya Niimi, Ayako Moritomo, Kenichi Mori, Masaya Orita · 2009 · Journal of Chemical Information and Modeling
10. Formal Concept Analysis for the Identification of Molecular Fragment Combinations Specific for Active and Highly Potent Compounds
    Eugen Lounkine, Jens Auer, Jürgen Bajorath · 2008 · Journal of Medicinal Chemistry
11. Concepts and Applications of “Natural Computing” Techniques in De Novo Drug and Peptide Design
    Jan A. Hiss, Markus Hartenfeller, Gisbert Schneider · 2010 · Current Pharmaceutical Design
12. Synthesis and antifungal activities in vitro of novel pyrazino [2,1-a] isoquinolin derivatives
    Hui Ru Tang, Canhui Zheng, Jiaguo Lv, Juan Wu, Yanan Li, Hui Yang, Bing‐yue Fu, Chuntong Li, Youjun Zhou, Jü Zhu · 2009 · Bioorganic & Medicinal Chemistry Letters
13. Second-generation de novo design: a view from a medicinal chemist perspective
    Andrea Zaliani, Krisztina Boda, Thomas Seidel, Achim Herwig, Christof H. Schwab, Johann Gasteiger, Holger Claußen, Christian Lemmen, Jörg Degen, Juri Pärn et al. · 2009 · Journal of Computer-Aided Molecular Design
14. The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA
    Andreas Schüller, Marcel Suhartono, Uli Fechner, Yusuf Tanrikulu, Sven Breitung, Ute Scheffer, Michael Göbel, Gisbert Schneider · 2007 · Journal of Computer-Aided Molecular Design
15. Chemical Database Mining through Entropy-Based Molecular Similarity Assessment of Randomly Generated Structural Fragment Populations
    José Batista, Jürgen Bajorath · 2006 · Journal of Chemical Information and Modeling
16. Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem
    Ruud van Deursen, Lorenz C. Blum, Jean‐Louis Reymond · 2011 · Journal of Computer-Aided Molecular Design
17. The use of ligand-based de novo design for scaffold hopping and sidechain optimization: Two case studies
    Miklós Fehér, Yinghong Gao, J. Christian Baber, William A. Shirley, John Saunders · 2007 · Bioorganic & Medicinal Chemistry
18. Sharing Chemical Information without Sharing Chemical Structure
    Brian B. Masek, Lingling Shen, Karl M. Smith, Robert S. Pearlman · 2008 · Journal of Chemical Information and Modeling
19. De Novo Design of a Picomolar Nonbasic 5-HT1BReceptor Antagonist
    David A. Nugiel, Jennifer R. Krumrine, Daniel C. Hill, James R. Damewood, Peter R Bernstein, Cynthia D. Sobotka‐Briner, JianWei Liu, Anna Zacco, M. Edward Pierson · 2010 · Journal of Medicinal Chemistry
20. NovoFLAP: A Ligand-Based De Novo Design Approach for the Generation of Medicinally Relevant Ideas
    James R. Jr. Damewood, Charles L. Lerman, Brian B. Masek · 2010 · Journal of Chemical Information and Modeling
21. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase
    Derek A. Cogan, Ronald A. Aungst, Eric C. Breinlinger, Tazmeen N. Fadra, Daniel R. Goldberg, Mengqiuyue Hao, Rachel Kroe‐Barrett, Neil Moss, Christopher Pargellis, K.C. Qian et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
22. The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design
    Christian R. Schubert, Collin M. Stultz · 2009 · Journal of Computer-Aided Molecular Design
23. Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase
    Anil K. Agarwal, A. Peter Johnson, Colin W. G. Fishwick · 2008 · Tetrahedron
24. Computational Techniques in Fragment Based Drug Discovery
    Hugo O. Villar, Mark H Hansen · 2007 · Current Topics in Medicinal Chemistry
25. From Molecular Shape to Potent Bioactive Agents II: Fragment‐Based de novo Design
    Ewgenij Proschak, Kerstin Sander, Heiko Zettl, Yusuf Tanrikulu, Oliver Rau, Petra Schneider, Manfred Schubert‐Zsilavecz, Holger Stark, Gisbert Schneider · 2008 · ChemMedChem
26. Mining of Randomly Generated Molecular Fragment Populations Uncovers Activity-Specific Fragment Hierarchies
    José Batista, Jürgen Bajorath · 2007 · Journal of Chemical Information and Modeling
27. Fragment Shuffling: An Automated Workflow for Three-Dimensional Fragment-Based Ligand Design
    Britta Nisius, Ulrich Rester · 2009 · Journal of Chemical Information and Modeling
28. Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program protobuild
    Yushma Bhurruth-Alcor, Therese Halvorsen Røst, Michael R. Jorgensen, Christos A. Kontogiorgis, Jon Skorve, Robert G. Cooper, Joseph M. Sheridan, William D. O. Hamilton, Jonathan R. Heal, Rolf Kristian Berge et al. · 2010 · Organic & Biomolecular Chemistry
29. Ring Systems in Mutagenicity Databases
    Richard Kho, Jason A. Hodges, Mark R. Hansen, Hugo O. Villar · 2005 · Journal of Medicinal Chemistry
30. FK506-Binding Protein Ligands: Structure-Based Design, Synthesis, and Neurotrophic/Neuroprotective Properties of Substituted 5,5-Dimethyl-2-(4-thiazolidine)carboxylates
    Liqin Zhao, Wei Huang, Hongying Liu, Lili Wang, Wu Zhong, Junhai Xiao, Yuan‐Dong Hu, Song Li · 2006 · Journal of Medicinal Chemistry
31. An ultra-fast LC method for the determination of iodiconazole in microdialysis samples and its application in the calibration of laboratory-made linear probes
    Ning Sun, Jun Wen, Guocai Lu, Zhanying Hong, Guorong Fan, Yutian Wu, Chunquan Sheng, Wannian Zhang · 2009 · Journal of Pharmaceutical and Biomedical Analysis
32. From Molecular Shape to Potent Bioactive Agents I: Bioisosteric Replacement of Molecular Fragments
    Ewgenij Proschak, Heiko Zettl, Yusuf Tanrikulu, Martin Weisel, Jan M. Kriegl, Oliver Rau, Manfred Schubert‐Zsilavecz, Gisbert Schneider · 2008 · ChemMedChem
33. Automatic Tailoring and Transplanting: A Practical Method that Makes Virtual Screening More Useful
    Yan Li, Yuan Zhao, Zhihai Liu, Renxiao Wang · 2011 · Journal of Chemical Information and Modeling
34. An liquid chromatography–tandem mass spectrometry assay for determination of trace amount of new antifungal drug iodiconazole in human plasma
    Shouhong Gao, Xia Tao, Lianna Sun, Chunquan Sheng, Wannian Zhang, Yunlei Yun, Jingxian Li, Haijun Miao, Wansheng Chen · 2008 · Journal of Chromatography B
35. Design and Evaluation of Fragment-Like Estrogen Receptor Tetrahydroisoquinoline Ligands from a Scaffold-Detection Approach
    Sabine Möcklinghoff, Willem A. L. van Otterlo, Rolf Rose, Sascha Fuchs, Tobias J. Zimmermann, Marta Domínguez, Herbert Waldmann, Christian Ottmann, Luc Brunsveld · 2011 · Journal of Medicinal Chemistry
36. 2D Depiction of Fragment Hierarchies
    Alex M. Clark · 2009 · Journal of Chemical Information and Modeling
37. Exploring fragment spaces under multiple physicochemical constraints
    Juri Pärn, Jörg Degen, Matthias Rarey · 2007 · Journal of Computer-Aided Molecular Design
38. Functional annotation strategy for protein structures
    Olivia Doppelt‐Azeroual, Fabrice Moriaud, Aurélie Bornot, Alexandre G. de Brevern · 2007 · Bioinformation
39. Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery
    M. Catherine Johnson, Qiyue Hu, Laura Lingardo, Rose Ann Ferre, Samantha E. Greasley, Jiangli Yan, John C. Kath, Ping Chen, Jacques Ermolieff, Gordon Alton · 2011 · Journal of Computer-Aided Molecular Design
40. Tetrabromobisphenol A: Investigating the worst-case scenario
    Robin J. Law · 2009 · Marine Pollution Bulletin
41. Reaction-MQL: Line Notation for Functional Transformation
    Felix Reisen, Gisbert Schneider, Ewgenij Proschak · 2008 · Journal of Chemical Information and Modeling
42. Fragment-based drug discovery using the SHAPES method
    Christopher A. Lepre · 2007 · Expert Opinion on Drug Discovery
43. Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARγ ligands (I)
    Xiaochun Dong, Zhenshan Zhang, Wen Ren, Jianhua Shen, Xu Shen, Hualiang Jiang · 2006 · Bioorganic & Medicinal Chemistry Letters
44. Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core
    Jon J. Hangeland, Daniel L. Cheney, Todd J. Friends, Stephen G. Swartz, Paul Lévesque, Adam J. Rich, Lucy R. Sun, Terry R. Bridal, Leonard P. Adam, Diane E. Normandin et al. · 2007 · Bioorganic & Medicinal Chemistry Letters
45. In Silico Fragment Screening by Replica Generation (FSRG) Method for Fragment-Based Drug Design
    Yoshifumi Fukunishi, Tadaaki Mashimo, Masaya Orita, Kazuki Ohno, Haruki Nakamura · 2009 · Journal of Chemical Information and Modeling
46. Structure-based design of substituted biphenyl ethylene ethers as ligands binding in the hydrophobic pocket of gp41 and blocking the helical bundle formation
    Bin Liu, Rhoda W. Joseph, Bruce D. Dorsey, Robert A. Schiksnis, Katrina Northrop, Marina V. Bukhtiyarova, Eric B. Springman · 2009 · Bioorganic & Medicinal Chemistry Letters
47. Using Computational Techniques in Fragment-Based Drug Discovery
    Renée L. DesJarlais · 2011 · Methods in enzymology on CD-ROM/Methods in enzymology
48. Computational Approaches for Fragment Optimization
    Eric Vangrevelinghe, Simon Rüdisser · 2007 · Current Computer - Aided Drug Design
49. Fragment-Based Prediction of the Clinical Occurrence of Long QT Syndrome and Torsade de Pointes
    Matthew Clark, Jeffrey S. Wiseman · 2009 · Journal of Chemical Information and Modeling
50. Constructing virtual combinatorial fragment libraries based upon MDL Drug Data Report database
    Min Zhang, Chunquan Sheng, Hui Xu, Yunlong Song, WanNian Zhang · 2007 · Science China Chemistry
51. FEP-Guided Selection of Bicyclic Heterocycles in Lead Optimization for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase [J. Am. Chem. Soc. 2006, 128, 15372−15373].
    Joseph T. Kim, Andrew D. Hamilton, Christopher M. Bailey, Robert A. Domaoal, Ligong Wang, Karen S. Anderson, William L. Jorgensen · 2007 · Journal of the American Chemical Society
52. High performance liquid chromatographic determination of a new antifungal compound, ADKZ in rat plasma
    Jing Wen, Guorong Fan, Zhanying Hong, Yifeng Chai, Xueping Yin, Yutian Wu, Chunquan Sheng, W.N. Zhang · 2006 · Journal of Pharmaceutical and Biomedical Analysis
53. Computational Approaches to Fragment and Substructure Discovery and Evaluation
    Eelke van der Horst, Adriaan P. IJzerman · 2008
54. Design and Synthesis of Novel Pyrazino[2,1‐a]isoquinolin Derivatives with Potent Antifungal Activity
    Hui Ru Tang, Canhui Zheng, Jü Zhu, Bing‐yue Fu, Youjun Zhou, Jiaguo Lv · 2010 · Archiv der Pharmazie
55. Fragment-based drug discovery: what really works. An interview with Sandy Farmer of Boehringer Ingelheim
    Wendy A. Warr · 2011 · Journal of Computer-Aided Molecular Design
56. Site-directed fragment-based generation of virtual sialic acid databases against influenza A hemagglutinin
    Mohammed Noor Al-qattan, Mohd Nizam Mordi · 2009 · Journal of Molecular Modeling
57. Structural Fragments in Marketed Oral Drugs
    Michal Vieth, Miles G. Siegel · 2006 · Methods and principles in medicinal chemistry
58. Cheminformatics Approaches to Fragment‐based Lead Discovery
    Tudor Ionel Oprea, Jeffrey M. Blaney · 2006 · Methods and principles in medicinal chemistry
59. The art and practice of structure-based drug design: A molecular modeling perspective
    1996
60. Untitled work
    1998 · 10.1002/(sici)1096-987x(19981115)19:14